tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

BeiGene’s Strategic Positioning and Growth Potential: A Buy Recommendation by Reni Benjamin
RatingsBeiGene’s Strategic Positioning and Growth Potential: A Buy Recommendation by Reni Benjamin
2d ago
ONC
BeiGene to discontinue development program for ociperlimab (BGB-A1217)
PremiumThe Fly
BeiGene to discontinue development program for ociperlimab (BGB-A1217)
3d ago
ONC
BeiGene receives positive CHMP opinion for Tevimbra
PremiumThe Fly
BeiGene receives positive CHMP opinion for Tevimbra
6d ago
ONC
BeiGene Reports Strong Revenue Growth and Reduced Losses for 2024
PremiumCompany Announcements
BeiGene Reports Strong Revenue Growth and Reduced Losses for 2024
10d ago
6160
BeiGene to Approve and Publish Annual Results in Hong Kong
PremiumCompany Announcements
BeiGene to Approve and Publish Annual Results in Hong Kong
23d ago
6160
BeiGene Secures Key HKEX Waivers to Enhance Strategic Operations
PremiumCompany AnnouncementsBeiGene Secures Key HKEX Waivers to Enhance Strategic Operations
23d ago
6160
BeiGene price target raised to $259 from $207 at Bernstein
Premium
The Fly
BeiGene price target raised to $259 from $207 at Bernstein
24d ago
ONC
BeiGene Completes Employee Share Purchase Plan
Premium
Company Announcements
BeiGene Completes Employee Share Purchase Plan
24d ago
6160
BeiGene Sets Record Date for 2025 Annual General Meeting
PremiumCompany Announcements
BeiGene Sets Record Date for 2025 Annual General Meeting
25d ago
6160
BeiGene Announces Internet Availability of Proxy Materials
PremiumCompany Announcements
BeiGene Announces Internet Availability of Proxy Materials
27d ago
6160
BeiGene Announces Proposed Domicile Change to Switzerland
PremiumCompany Announcements
BeiGene Announces Proposed Domicile Change to Switzerland
27d ago
6160
BeiGene Ltd Plans Strategic Move to Switzerland
PremiumCompany Announcements
BeiGene Ltd Plans Strategic Move to Switzerland
27d ago
6160
BeiGene’s Strong Market Position and Growth Potential: A Buy Rating by Reni Benjamin
PremiumRatingsBeiGene’s Strong Market Position and Growth Potential: A Buy Rating by Reni Benjamin
1M ago
ONC
BeiGene announces FDA approval of Tevimbra/chemotherapy combination
Premium
The Fly
BeiGene announces FDA approval of Tevimbra/chemotherapy combination
1M ago
ONC
BeiGene upgraded to Buy from Neutral at BofA
Premium
The Fly
BeiGene upgraded to Buy from Neutral at BofA
1M ago
ONC
BeiGene’s Strong Market Position and Growth Potential Driven by Zanubrutinib Sales and Promising Financial Outlook
PremiumRatings
BeiGene’s Strong Market Position and Growth Potential Driven by Zanubrutinib Sales and Promising Financial Outlook
1M ago
ONC
BeiGene’s Strong Financial Performance and Promising Outlook Earns Buy Rating from Analyst
PremiumRatings
BeiGene’s Strong Financial Performance and Promising Outlook Earns Buy Rating from Analyst
1M ago
ONC
BeiGene, Ltd. Files Amended Annual Report with SEC
PremiumCompany Announcements
BeiGene, Ltd. Files Amended Annual Report with SEC
1M ago
6160
BeiGene, Ltd. Announces Board of Directors and Committee Roles
PremiumCompany Announcements
BeiGene, Ltd. Announces Board of Directors and Committee Roles
1M ago
6160
BeiGene granted orphan designation for sonrotoclax
PremiumThe FlyBeiGene granted orphan designation for sonrotoclax
1M ago
ONC
BeiGene price target raised to $313 from $259 at Macquarie
Premium
The Fly
BeiGene price target raised to $313 from $259 at Macquarie
1M ago
ONC
BeiGene price target raised to $348 from $345 at Guggenheim
Premium
The Fly
BeiGene price target raised to $348 from $345 at Guggenheim
1M ago
ONC

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >